Emerging Treatments for Schizophrenia in the Pipeline
After more than 70 years of antipsychotic medications that are mere iterations of earlier discoveries, a door may have cracked open to offer better options for individuals struggling with severe mental illness. There is much more research to be done, said Dr. Jacob Ballon, who specializes in the treatment of individuals with psychotic disorders including schizophrenia and is Co-Director of the INSPIRE Clinic at Stanford.